Clinical Trials Details

S1612 (Leukemia)

Randomized Phase II/III Trial of Novel Therapeutics VS. Azacytadine in Newly Diagnosed patients with AML or High Risk MDS Age 60 or older

Objective

This clinical trial was temporary closed to patient accrual on Oct. 22, 2018.

Clinical Trial Categories

  • Cancers and Other Neoplasms